TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Genetics of Neurodegenerative Disease: Neurochip and Beyond

                      Workshop     Participant List     Executive Summary

Day 1    
9:00 a.m. Welcome and Introduction of Workshop Goals John Hardy
9:10 a.m. NeuroGenetics Research Consortium (NGRC)
Nat Genet. 2010, 42(9):781-5.
Haydeh Payami
9:30 a.m. PD GWAS in Dutch Cohort
Eur J Hum Genet. 2011 (epub).
Peter Heutink
9:50 a.m. PD GWAS in Asian Cohort
Nat Genet. 2009, 41(12):1303-7. Neurology. 2010, 75(6):508-12.
Wataru Satake
10:10 a.m. UK PD Consortium, Welcome Trust Case Control Consortium
Hum Mol Genet. 2011, 20(2):345-53.
Nick Woods (John Hardy)
10:30 a.m. BREAK  
11:00 a.m. PD GWAS in French Cohort
Hum Mol Genet. 2011, Feb 1;20(3):615-27. Epub 2010 Nov 17.
Maria Martinez
11:20 a.m. 23andMe PD Genetic Analysis Chuong Do
11:40 a.m. PD Gene Database
Lars Bertram
12:00 p.m. LUNCH  
1:00 p.m. International PD Genomics Consortium
Lancet. 2011, 377(9766):641-49.
Andy Singleton
1:30 p.m. USA PD GWAS Consortium Tatiana Foroud
2:00 p.m. Mega Meta Analysis of PD and Control Datasets―Next Steps John Hardy and Gerard Schellenberg
3:00 p.m. BREAK (All participants are welcome to join the meeting.)  
3:30 p.m. Plan and Timeline for Moving Forward John Hardy, Margaret Sutherland
4:00 p.m. Phenotype-Genotype Integrator (PheGenI)
Lucia Hindorff
4:15 p.m. Genetic Architecture of Disease Henry Houlden
4:45 p.m. Consensus Disease Pathways Jeff Vance
5:15 p.m. End of Day 1  
6:30‒8:30 p.m. RECEPTION (all participants)  
  Lessons Learned From Immunochip and Cardio-Metabochip Illumina
Sarah Neugebauer
  Neurochip Design: Leverage Validated Content and Flexible Array Formats Affymetrix
Andrea Finn
Day 2    
9:00 a.m. Introduction to the NeuroChip Initiative  John Hardy
9:20 a.m. Summary of AD GWAS  Julie Williams, Gerard Schellenberg, Philippe Amouyel, Lindsay Farrer, Ekaterina Rogaeva
10:20 a.m. Summary of PSP GWA Studies  Gerard Schellenberg
10:40 a.m. BREAK  
11:00 a.m. Summary of Stroke GWA Studies  Michael Nalls
11:20 a.m. Summary of MSA GWA Studies  Henry Houlden
11:40 a.m. Summary of FTD GWA Studies  Vivianna Van Deerlin
12:10 p.m. LUNCH  
1:10 p.m. Summary of PD GWA Studies Andy Singleton, Tatiana Foroud
1:50 p.m. Summary of ALS GWA Studies Bob Brown, Bryan Traynor, Leonard van den Berg, Ammar Al Chalabi
2:20 p.m. Summary of MS GWA Studies Peggy Pericak-Vance
2:50 p.m. BREAK  
3:10 p.m. NeuroChip Discussion―Criteria, Development, and Implementation John Hardy
3:50 p.m. Inclusion of Known Mutations, SNPs for Drug Toxicities Marc Cruts
4:10 p.m. Next Steps―Timeline for Development and Implementation John Hardy, Margaret Sutherland
5:00 p.m. End of Meeting  

Last updated December 23, 2013